These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 11816712
1. The Kringle V-protease domain is a fibrinogen binding region within Apo(a). Xue S, Madison EL, Miles LA. Thromb Haemost; 2001 Nov; 86(5):1229-37. PubMed ID: 11816712 [Abstract] [Full Text] [Related]
2. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules. Xue S, Green MA, LoGrasso PV, Boettcher BR, Madison EL, Curtiss LK, Miles LA. Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473 [Abstract] [Full Text] [Related]
3. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface. Sangrar W, Gabel BR, Boffa MB, Walker JB, Hancock MA, Marcovina SM, Horrevoets AJ, Nesheim ME, Koschinsky ML. Biochemistry; 1997 Aug 26; 36(34):10353-63. PubMed ID: 9265615 [Abstract] [Full Text] [Related]
4. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots. Sangrar W, Koschinsky ML. Biochem Cell Biol; 2000 Aug 26; 78(4):519-25. PubMed ID: 11012092 [Abstract] [Full Text] [Related]
5. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10. Belczewski AR, Ho J, Taylor FB, Boffa MB, Jia Z, Koschinsky ML. Biochemistry; 2005 Jan 18; 44(2):555-64. PubMed ID: 15641780 [Abstract] [Full Text] [Related]
6. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding. Chenivesse X, Huby T, Wickins J, Chapman J, Thillet J. Biochemistry; 1998 May 19; 37(20):7213-23. PubMed ID: 9585533 [Abstract] [Full Text] [Related]
7. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding. Rahman MN, Petrounevitch V, Jia Z, Koschinsky ML. Protein Eng; 2001 Jun 19; 14(6):427-38. PubMed ID: 11477223 [Abstract] [Full Text] [Related]
8. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site. Anglés-Cano E, Rojas G. Biol Chem; 2002 Jan 19; 383(1):93-9. PubMed ID: 11928826 [Abstract] [Full Text] [Related]
9. A structural assessment of the apo[a] protein of human lipoprotein[a]. Guevara J, Knapp RD, Honda S, Northup SR, Morrisett JD. Proteins; 1992 Feb 19; 12(2):188-99. PubMed ID: 1318546 [Abstract] [Full Text] [Related]
10. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes. Klezovitch O, Edelstein C, Scanu AM. J Clin Invest; 1996 Jul 01; 98(1):185-91. PubMed ID: 8690792 [Abstract] [Full Text] [Related]
11. Cloning, expression, and characterization of human apolipoprotein(a) kringle IV37. LoGrasso PV, Cornell-Kennon S, Boettcher BR. J Biol Chem; 1994 Aug 26; 269(34):21820-7. PubMed ID: 8063825 [Abstract] [Full Text] [Related]
12. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a). Chitayat S, Kanelis V, Koschinsky ML, Smith SP. Biochemistry; 2007 Feb 20; 46(7):1732-42. PubMed ID: 17263558 [Abstract] [Full Text] [Related]
13. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation. Becker L, Cook PM, Koschinsky ML. Biochemistry; 2004 Aug 10; 43(31):9978-88. PubMed ID: 15287725 [Abstract] [Full Text] [Related]
14. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site. Ahn JH, Lee HJ, Lee EK, Yu HK, Lee TH, Yoon Y, Kim SJ, Kim JS. Biol Chem; 2011 Apr 10; 392(4):347-56. PubMed ID: 21194375 [Abstract] [Full Text] [Related]
15. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation. Martínez C, Rivera J, Loyau S, Corral J, González-Conejero R, Lozano ML, Vicente V, Anglés-Cano E. Thromb Haemost; 2001 Apr 10; 85(4):686-93. PubMed ID: 11341506 [Abstract] [Full Text] [Related]
16. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody. Kang C, Dominguez M, Loyau S, Miyata T, Durlach V, Anglés-Cano E. Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1232-8. PubMed ID: 12117743 [Abstract] [Full Text] [Related]
17. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance. Mochalkin I, Cheng B, Klezovitch O, Scanu AM, Tulinsky A. Biochemistry; 1999 Feb 16; 38(7):1990-8. PubMed ID: 10026282 [Abstract] [Full Text] [Related]
18. Direct interaction of the extracellular matrix protein DANCE with apolipoprotein(a) mediated by the kringle IV-type 2 domain. Kapetanopoulos A, Fresser F, Millonig G, Shaul Y, Baier G, Utermann G. Mol Genet Genomics; 2002 Jun 16; 267(4):440-6. PubMed ID: 12111551 [Abstract] [Full Text] [Related]
19. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. Gabel BR, Koschinsky ML. Biochemistry; 1998 May 26; 37(21):7892-8. PubMed ID: 9601051 [Abstract] [Full Text] [Related]
20. Bacterial expression and characterization of human recombinant apolipoprotein(a) kringle IV type 9. Chung FZ, Wu LH, Lee HT, Mueller WT, Spahr MA, Eaton SR, Tian Y, Settimi PD, Oxender DL, Ramharack R. Protein Expr Purif; 1998 Jul 26; 13(2):222-8. PubMed ID: 9675066 [Abstract] [Full Text] [Related] Page: [Next] [New Search]